Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan

With regard to the use of rituximab for patients with steroid-dependent nephrotic syndrome and frequently relapsing nephrotic syndrome, not only has the regimen not been clinically verified but also there is a lack of health economics evidence. Therefore, we conducted a prospective clinical study on...

Descripción completa

Detalles Bibliográficos
Autores principales: Takura, Tomoyuki, Takei, Takashi, Nitta, Kosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384079/
https://www.ncbi.nlm.nih.gov/pubmed/28387313
http://dx.doi.org/10.1038/srep46036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384079/
https://www.ncbi.nlm.nih.gov/pubmed/28387313
http://dx.doi.org/10.1038/srep46036

Ejemplares similares